← Alle mensen

AD

Adi Diab

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Gerandomiseerde, Open-Label, Fase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 mei 2025

Bempegaldesleukin plus nivolumab bij onbehandeld melanoom: PIVOT IO 001 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 oktober 2023

Pembrolizumab plus gereduceerd-dosis ipilimumab bij melanoom: KEYNOTE-029 cohort 2 langetermijn

Clinical cancer research : an official journal of the American Association for Cancer Research · 1 oktober 2021

Neoadjuvant plus adjuvant dabrafenib-trametinib bij hoogrisico BRAF-gemuteerd melanoom: NeoCombi

The Lancet. Oncology · 2018-02

Ipilimumab met stereotactische ablatieve radiotherapie: fase I-resultaten en immunologische correlaten

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 maart 2017